Skip to main content
SpringerLink
Log in

The protective effect of the Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ (PPARγ) isoform 2 in progression to diabetes in a Pakistani cohort

  • Original Article
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

Diabetes is a serious health issue in Pakistan with 6.9 million cases of diabetes and 87,548 deaths due to diabetes in Pakistan in 2014. Peroxisome proliferators-activated receptors are transcription factors, regulating several physiological processes The aims of the current study were to determine the prevalence of Pro12Ala polymorphism (C>G) of PPAR-y iso-form 2 gene and analyze its effect on selected anthropometric and biochemical parameters in a Pakistani cohort. We collected 926 samples, 500 healthy controls (fasting blood sugar < 99 mg/dL, random blood sugar < 126 mg/dL) and 426 cases with diabetes (fasting blood sugar > 99 mg/dL, random blood sugar > 126 mg/dL). The genotyping was done and serum biochemical parameters were determined. The results showed allelic frequency C = 0.716 and G = 0.284 in controls and C = 0.766 and G = 0.234 in diabetic cases; whereas, genotypic frequency was CC = 52.2%, CG = 38.8%, and GG = 9% in controls and CC = 57.7%, CG = 37.8%, GG = 4.5% in cases. The association of Pro12Ala polymorphism under additive, dominant, and recessive models was checked (additive OR 0.58, CI 0.44–0.77, p value 0.0002, dominant OR 0.60, CI 0.44–0.82, p value 0.001, recessive OR 0.36, CI 0.15–0.86, p value 0.016). The result showed that the polymorphism is significantly associated with the decreased risk of diabetes in the Pakistani study subjects under additive models. The variant showed an association with weight, BMI, blood glucose, TC, HDL-C, insulin, and HOMA-IR. In conclusion, the presence of minor allele lowers the risk of diabetes and the effect may involve modulating serum glucose and lipid levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kaul K, Tarr JM, Ahmad SI, Kohner EM, Chibber R. Introduction to diabetes mellitus. In: Diabetes: Springer; 2013. p. 1–11.

  2. Bahadar H, Mostafalou S, Abdollahi M. Growing burden of diabetes in Pakistan and the possible role of arsenic and pesticides. J Diabetes Metab Disord. 2014;13:117.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Youssef J, Badr MZ. PPARs: history and advances. In: Peroxisome proliferator-activated receptors (PPARs): Springer; 2013. p. 1–6.

  4. Schild RL, Schaiff WT, Carlson MG, Cronbach EJ, Nelson DM, Sadovsky Y. The activity of PPARγ in primary human trophoblasts is enhanced by oxidized lipids. J Clin Endocrinol Metab. 2002;87:1105–10.

    CAS  PubMed  Google Scholar 

  5. Ikezoe T, et al. Mutational analysis of the peroxisome proliferator-activated receptor γ gene in human malignancies. Cancer Res. 2001;61:5307–10.

    CAS  PubMed  Google Scholar 

  6. Sánchez JG, Rios MS, Pérez CF, Laakso M, Larrad MM. Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. Eur J Endocrinol. 2002;147:495–501.

    Article  Google Scholar 

  7. Fajas L, et al. Regulation of peroxisome proliferator-activated receptor γ expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism. Mol Cell Biol. 1999;19:5495–503.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Braissant O, Foufelle F, Scotto C, Dauça M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha,-beta, and-gamma in the adult rat. Endocrinology. 1996;137:354–66.

    Article  CAS  PubMed  Google Scholar 

  9. Yen C-J, et al. Molecular scanning of the human peroxisome proliferator activated receptor γ (hPPARγ) gene in diabetic Caucasians: identification of a Pro12Ala PPARγ2 missense mutation. Biochem Biophys Res Commun. 1997;241:270–4.

    Article  CAS  PubMed  Google Scholar 

  10. Altshuler D, et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000;26:76–80.

    Article  CAS  PubMed  Google Scholar 

  11. Tönjes A, Scholz M, Loeffler M, Stumvoll M. Association of Pro12Ala polymorphism in peroxisome proliferator–activated receptor γ with pre-diabetic phenotypes meta-analysis of 57 studies on nondiabetic individuals. Diabetes Care. 2006;29:2489–97.

    Article  PubMed  Google Scholar 

  12. Badii R, et al. Lack of association between the Pro12Ala polymorphism of the PPAR-γ2 gene and type 2 diabetes mellitus in the Qatari consanguineous population. Acta Diabetol. 2008;45:15–21.

    Article  CAS  PubMed  Google Scholar 

  13. Ghoussaini M, et al. Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population. BMC Med Genet. 2005;6:11.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Hara K, et al. The Pro12Ala polymorphism in PPAR γ2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun. 2000;271:212–6.

    Article  CAS  PubMed  Google Scholar 

  15. Shabana, Hasnain S. Association of the leptin receptor Gln223Arg polymorphism with lipid profile in obese Pakistani subjects. Nutrition. 2015;31:1136–40.

    Article  CAS  PubMed  Google Scholar 

  16. Masud S, Ye S. Effect of the peroxisome proliferator activated receptor-γ gene Pro12Ala variant on body mass index: a meta-analysis. J Med Genet. 2003;40:773–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Jalil SF, Ahmed I, Gauhar Z, Ahmed M, Malik JM, John P, et al. Association of Pro12Ala (rs1801282) variant of PPAR gamma with rheumatoid arthritis in a Pakistani population. Rheumatol Int. 2014;34:699–703.

    Article  CAS  PubMed  Google Scholar 

  18. Bener A, Zirie M, Al-Hamaq A, Nawaz Z, Samson N, Mohammad R. Impact of the Pro12Ala polymorphism of the PPARγ2 gene on diabetes and obesity in a highly consanguineous population. Indian J Endocrinol Metab. 2015;19:77.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Vimaleswaran KS, Radha V, Jayapriya MG, Ghosh S, Majumder PP, Rao MS, et al. Evidence for an association with type 2 diabetes mellitus at the PPARG locus in a South Indian population. Metabolism. 2010;59:457–62.

    Article  CAS  PubMed  Google Scholar 

  20. Ringel J, Engeli S, Distler A, Sharma AM. Pro12Ala missense mutation of the peroxisome proliferator activated receptor γ and diabetes mellitus. Biochem Biophys Res Commun. 1999;254:450–3.

    Article  CAS  PubMed  Google Scholar 

  21. Mirzaei H, Akrami SM, Golmohammadi T, Doosti M, Heshmat R, Nakhjavani M, et al. Polymorphism of Pro12Ala in the peroxisome proliferator-activated receptor γ2 gene in Iranian diabetic and obese subjects. Metab Syndr Relat Disord. 2009;7:453–8.

    Article  CAS  PubMed  Google Scholar 

  22. Mori H, et al. The Pro12→ Ala substitution in PPAR-γ is associated with resistance to development of diabetes in the general population possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes. 2001;50:891–4.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Punjab Institute of cardiology is also acknowledged for providing the patients’ blood samples.

Funding

The study was supported by the University of the Punjab research and project grant.

Author information

Authors and Affiliations

  1. Department of Microbiology and Molecular Genetics, University of the Punjab, Lahore, Pakistan

    Khushbakht, Sumbal Sarwar &  Shabana

Authors
  1. Khushbakht
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sumbal Sarwar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shabana
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shabana.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khushbakht, Sarwar, S. & Shabana The protective effect of the Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ (PPARγ) isoform 2 in progression to diabetes in a Pakistani cohort. Int J Diabetes Dev Ctries 38, 238–242 (2018). https://doi.org/10.1007/s13410-017-0588-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13410-017-0588-8

Keywords

Search

Navigation